Rita Cortesi
Rita Cortesi
Department of Life Sciences and Biotechnology,
University of Ferrara,
Italy
Biography
Rita Cortesi graduated in Chemistry and Pharmaceutical Technology in 1991 from the University of Ferrara. In 1992 habilitate Exercise of the Profession of Pharmacist. In 1995 she became Doctor of Philosophy in Pharmaceutical Sciences and obtained a PhD fellow of 12 months at Nottingham University (Prof. SS Davis guardian) under the Human Capital and Mobility Project of the EEC. In 1997 she hold a post-doctoral scholarship for the project "Microparticulate systems for the controlled release of drugs" at UNIFE. In 1997 she became a Teaching assistant and in 1999 became Assistant Professor. In 2006 she qualified as Associate Professor, a role she has held since 31/12/2008 at UNIFE. In 2006 she was co-founder of entrepreneurial initiative CoReS Techno. Since 2009 she is member of the Scientific Council of the Inter-University Consortium TEFARCO. From 2009 to 2012 is part of the Academic Board for a Ph.D. in Pharmaceutical Sciences and from 2013 is part of the Academic Board for a Ph.D. in Chemistry at UniFe. She got the entitlement to Full Professor (sector 03/D2) on 01/31/2014. Since 2000 she has been teaching in the scientific field of belonging. She is part of the Editorial Advisory Board of several international journals in the field of technology. She is member of Italian and international scientific associations. Dr. Cortesi has participated in almost hundred international conferences and has authored more than 100 publications in international scientific journals.
Research Interest
Dr. Rita's research interest includes Micro- and Nano-technology for delivery of nucleic acids, Formulative studies of micro- and nanosystems for drug delivery in cancer, viral diseases, degenerative diseases, Innovative strategies for drug delivery on/through the skin, Development of supramolecular systems for lipophilic drugs, Development of semisolid formulations containing nanoparticles, Engineering of solid lipid nanoparticles for brain targeting.